Compare Mutual Funds
WhiteOak Capital Pharma and Healthcare Fund
EquitySectoral-Pharma
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.74
-
NAV
₹16.63
-
Fund Started
16 Jan 2024
-
Fund Size
₹1002.75 Cr
-
Exit Load
-
-
1 Year
12.89%
-
3 Year
-
-
5 Year
-
-
Equity
91.43%
-
Cash
0.53%
-
Top 10 Holdings
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 7.73% |
Sun Pharmaceutical Industries Ltd. | 6.57% |
Torrent Pharmaceuticals Ltd. | 5.78% |
Laurus Labs Ltd. | 3.61% |
Apollo Hospitals Enterprise Ltd. | 3.47% |
Cipla Ltd. | 3.40% |
Sai Life Sciences Ltd. | 3.03% |
Ipca Laboratories Ltd. | 2.66% |
Zydus Lifesciences Ltd. | 2.60% |
Neuland Laboratories Ltd. | 2.40% |
-
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
-
Launch Date
16 Jan 2024
-
